No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Is the Options Market Predicting a Spike in BioMarin Pharmaceutical (BMRN) Stock?
Does BioMarin Pharmaceutical (NASDAQ:BMRN) Have A Healthy Balance Sheet?
Worst Performing Stocks for Tax Loss Selling – Wolfe
BioMarin Pharmaceutical Price Target Maintained With a $90.00/Share by Cantor Fitzgerald
Are BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
11 Compounder Opportunities According to Goldman: AMD, BDX, INFA